Bempedoic acid & Bempedoic acid with ezetimibe

Status:: Grey
Decision Date:: July 2021

Comments

GREY:

NICE TA694: Bempedoic acid with Ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia: when a statin is contraindicated or not tolerated, and ezetimibe alone does not control low-density lipoprotein cholesterol well enough.

(Bempedoic acid - Nilemdo, Bempedoic acid/ezetimibe - Nustendi)

Brown Drug Classifications

6: NICE guidance